The Headway Study

Study Objective:

• The study is exploring a method to test if a drug can block a particular protein in the body known as Neurokinin 3 (NK3). The data and understanding from this study, will help determine if a new drug is promising and what doses might work for treating neurological conditions in the future.
• The study drug will be administered via a manual-push intravenous infusion (IV).

Importance of Clinical Trials:

• Clinical Trials are essential for advancing medical treatments and solutions, and they provide crucial insight with assessing the safety and effectiveness of emerging medications and therapies. The role of healthy volunteers is fundamental.
• These trials provide valuable data on the way the human body metabolizes and process new treatments ensuring they meet strict safety and efficacy standards before being made available to the public.

Clinical Trial Details:

• An independent ethics committee has approved this clinical trial.
• Participants will be reimbursed for their time
  

Call us on 1800 243 733 to discuss your eligibility today!